Republic Republic Republic
  • Log in
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Republic Venture Opportunities for accredited investors
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Log in Sign up

Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US
  • Log in
  • Sign up
All investors
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Accredited only
Republic Venture Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Spotlight deal
Hamilton Lane Private Infrastructure Fund
Hamilton Lane Private Infrastructure Fund
Get unique access to the full spectrum of private markets with Hamilton Lane
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets
Sharedrops Gift equity as a reward
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

Stream Dx isn't accepting new investments

Stream Dx’s deadline was February 10, 2022

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of Stream Dx

Stream Dx

Helping doctors collect urine flow data at home to improve healthcare outcomes
Veteran Founders B2B Healthcare Healthcare Services
Facebook Telegram Twitter LinkedIn
Featured image of Stream Dx
$104,270
Raised
185
Investors
Successfully funded and closed on February 10, 2022.
Invest in Stream Dx

Open for investment

Investors in Stream Dx also invested in these companies. View more
Logo of Eli Roth's The Horror Section

Eli Roth's The...

A brand-new independent studio from an iconic horror...

Republic Funding Portal · Reg CF
Logo of Freedom Chat

Freedom Chat

A private social messaging app transforming the soci...

Republic Funding Portal · Reg CF
Logo of RYSE

RYSE

Smart Shades for your Smart Home - over $9mm in sale...

Capital R · Reg A+
Loading...
Pitch Updates 5 Reviews 28
Invest Invest in Stream Dx
Facebook Telegram Twitter LinkedIn
Closed on February 10, 2022. Information may not be up-to-date. Campaign closed on February 10, 2022. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Funding Founders
About Team

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Stream Dx Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Stream Dx Crowd SAFE Stream Dx Form C.pdf
Loading

Hear from some of the 185 investors in Stream Dx


Show more

Highlights


$1M+ raised
Company has previously raised over $1M in capital
  • Assists physicians with developing treatment plans for LUTS patients
  • Better data & better service means better patient care
  • Supported by research published in the Journal of Urology (April 2021)
  • Recipient of 2 NIH SBIR grants worth $4.4M+ combined
  • YoY revenue increase from $21K (2019) to $91K (2020)
  • Recurring revenue fee-based service model
  • Addressable worldwide market – 1B males suffer from LUTS

Problem


50% of men over 50 suffer from Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms (LUTS) is one of the most common diagnosis made by urologists for men aged 45-74 in the U.S. and results in more than half a billion dollars of unnecessary emergency room visits per year.

Common causes of LUTS are underlying conditions such as BPH and an over-active bladder.

One tool that urologists use to diagnose LUTS is a uroflow test. 

In-clinic uroflow tests are inefficient and do not provide sufficient data

Until recently, uroflow testing has only been available in a clinic setting where it hinders workflow.

Solution


Stream Dx enables the doctors to perform uroflow testing at home

Stream Dx provides doctors the ability to offer home uroflow testing as a service. The data is collected using the Stream Dx Home Uroflowmeter, a patented, FDA registered, point of care device designed by Stream Dx to measure the flow rate, flow pattern, total volume, and time of day of urination.

Doctors like our service because we provide them with more and better data to help develop individualized treatment plans, as well as quantify the efficacy of medication therapies and surgical procedures.

The need for the Stream Dx Home Uroflow Service is even more relevant today, as Medicare and other insurance companies place more emphasis on Telehealth and Remote Patient Monitoring.

Product


Stream Dx allows for data collection from the comfort of one's home

Our home uroflow testing service improves clinic workflow because the doctor and their staff never have to handle a single device. The only thing a doctor has to do is order the test and then review the results once available.


We handle the entire testing process, including contacting the patient to go over instructions, shipping the device to the patient, following up with the patient to ensure compliance, and generating a detailed report for doctors to review.

We are always improving our home testing service. We will introduce Version 2 of our Uroflowmeter in 2022. The new design will allow us to enter into new segments of the LUTS markets.

Traction


YoY sales growth, and recipient of 2 NIH grants worth $4.4M+ combined

Stream Dx generated $21K in revenue in 2019 and $91K in 2020.

Patients have successfully recorded over 90K urination events using the Stream Dx home testing service.

Stream Dx has been awarded $4.4M in nondilutive National Institute of Health (NIH) SBIR grants to cover R&D expenses for the development of our Version 1 and Version 2 Uroflowmeters. Both grant awards were scientifically and commercially peer reviewed.

Customers


More data. Less hassle.

Stream Dx handles every step of the data collection process, so physicians can focus on delivering quality care to their patients.

Business model


Recurring revenue fee-based service model

Stream Dx’s business model is a recurring revenue fee-based service model. Stream Dx generates income by charging physicians a fee of $65-$75 per use of the Home Uroflow Service. A physician purchases Home Uroflow Service credits, which are used each time a test is ordered.


Market


Over 1B males suffer from LUTS worldwide

Stream Dx is initially focusing on the $250M US male LUTS market. We will roll out our home uroflow testing service to targeted states over the next two years. We also plan to enter into the addressable worldwide male LUTS market consisting of over 1B men.

Competition


Best in class performance

Stream Dx is currently one of the only FDA-registered, at-home urinary testing products available in the U.S. Unlike our competitors, we provide complete fulfillment and patient management services.

Vision and strategy


Plans to exit within 5 years

Stream Dx is planning a possible exit in the next 3 to 5 years. We have identified four market segments that both have a use and a need for our service.

Funding


$1.9M raised from accredited angel investors

In addition to our grant funding, Stream Dx has raised $1.9M from accredited angel investors, urologists, and founders. 

We are now raising funds to scale our sales and production to meet our revenue projections.

Founders


Deal terms


Valuation cap

$6,500,000

The maximum valuation at which your investment converts into equity shares or cash.
Learn more

Minimum investment

$200

The smallest investment amount that Stream Dx is accepting.
Learn more

Maximum investment

$100,000

The largest investment amount that Stream Dx is accepting.
Learn more

Funding goal

$1.07M

Stream Dx must achieve its minimum goal of $25K before the deadline. The maximum amount the offering can raise is $1.07M.
Learn more

Deadline
Stream Dx needs to reach their minimum funding goal before the deadline ( ). If they don’t, all investments will be refunded.
Learn more
Type of security

Crowd SAFE

A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event. · Learn more

How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Stream Dx Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Stream Dx Crowd SAFE Stream Dx Form C.pdf

Bonus perks

In addition to your Crowd SAFE, you'll receive perks for investing in Stream Dx.
Invest
$1,000
Receive
  • Personal thank you note from the Stream Dx management team.
Invest
$5,000
Receive
  • Commemorative Stream Dx Uroflowmeter V1 Sleeve signed by Stream Dx management.
  • Personal thank you note from the Stream Dx management team.
Invest
$25,000
Receive
  • Exclusive one-on-one 60 minute video call with Stream Dx's CEO to learn more about the future of Stream Dx and the Telehealth landscape.
  • Commemorative Stream Dx Uroflowmeter Sleeve V1 signed by Stream Dx management.
  • Personal thank you note from the Stream Dx management team.

About Stream Dx

Legal Name
Stream Dx Inc
Founded
Oct 2014
Form
Utah Corporation
Employees
10
Website
streamdx.com
Social Media
Headquarters
Google Map location of of Stream Dx
429 W Lawndale Drive , South Salt Lake, UT
Headquarters
429 W Lawndale Drive, South Salt Lake, UT, United States 84115

Stream Dx Team
Everyone helping build Stream Dx, not limited to employees

Profile picture of Brian Holt
Brian Holt
CEO and Chairman
25+ years of startup and senior executive experience as a CEO, COO, and CFO in both large and small private and public companies.
Profile picture of Scott McClellan
Scott McClellan
CTO
25+ years of professional engineering experience with several successful data analytics and communication startup companies.
Profile picture of Mark Robinson
Mark Robinson
Director of Sales
15+ years of senior medical device sales experience including urology products.
Profile picture of Alvin Le
Alvin Le
Senior R&D Engineer
6+ years of research and development experience including software development and medical device design.
Profile picture of Kent Ogden
Kent Ogden
Senior R&D Engineer
6+ years of research and development experience including Solid Works assisted mold design, parts production, and medical device design.
Profile picture of Dr. Dinesh Patel
Dr. Dinesh Patel
Board Member
Managing Director of Patel Family Investments. Co-founder of Spring Capital. Co-founder of Theratech with a successful exit.
Profile picture of Dr. James Hotaling
Dr. James Hotaling
Board Member
Assistant Professor of Urology, University of Utah. Co-inventor of Stream Dx. Fellowship training focusing on the medical and surgical treatments of LUTS, erectile dysfunction, and male infertility.
Profile picture of Phil Grimm
Phil Grimm
Board Member
Former Executive Director of Salt Lake City Angels. 25 plus years of C-Suite experience in large and small private and public companies. Former Entrepreneur in Residence at Utah State University.
Profile picture of Kelly Powers
Kelly Powers
Board Member
Former Senior Vice President, Science & Technology at C. R. Bard. Responsible for global market development for all divisions of C. R. Bard (Access Systems, Peripheral Vascular, Davol, Medical, and Lutonix).
6 more team members
Brian Holt
CEO and Chairman
Scott McClellan
CTO
Mark Robinson
Director of Sales
Alvin Le
Senior R&D Engineer
Kent Ogden
Senior R&D Engineer
Dr. Dinesh Patel
Board Member
Dr. James Hotaling
Board Member
Phil Grimm
Board Member
Kelly Powers
Board Member
Logo of Stream Dx

Stream Dx

Stream Dx successfully raised $104,270 from 185 investors on February 10, 2022
Profile picture of Edele Vise
Profile picture of Takashi Sengoku
Profile picture of Muhammad Fard
Profile picture of Martin Horansky
Profile picture of Jack B Kirby Jr
Edele, Takashi, Muhammad, Martin, Jack B, and 180 others invested. 28 Reviews
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Instruments
  • Crowd SAFE
  • Tokenized assets
Company
  • About
  • Journal
  • Events
  • Contact
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BankProv, member FDIC / member DIF. FDIC coverage only applies in the event of bank failure. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BankProv and are not guaranteed by BankProv. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC